AEG‐1 can regulate cancer invasion through upregulation of matrix metalloproteinase‐9 (MMP9), matrix metalloproteinase‐2 (MMP2), and activation of NF‐κB signaling pathway 13, 16, 25, 26, 27. This evidence concerns the gene MMP9 and cancer.